Search results
Results from the WOW.Com Content Network
The targets should also be common across many strains of a virus, or even among different species of virus in the same family, so a single drug will have broad effectiveness. For example, a researcher might target a critical enzyme synthesized by the virus, but not by the patient, that is common across strains, and see what can be done to ...
Language links are at the top of the page across from the title.
Tabular cross-bedding, or planar bedding consists of cross-bedded units that are extensive horizontally relative to the set thickness and that have essentially planar bounding surfaces. [3] Trough cross-bedding, on the other hand, consists of cross-bedded units in which the bounding surfaces are curved, and hence limited in horizontal extent.
The term is variously used to refer to viral particles shedding from a single cell, from one part of the body into another, [2] and from a body into the environment, where the virus may infect another. [3] Vaccine shedding is a form of viral shedding which can occur in instances of infection caused by some attenuated (or "live virus") vaccines.
Hemagglutinin esterase (HEs) is a glycoprotein that certain enveloped viruses possess and use as an invading mechanism. HEs helps in the attachment and destruction of certain sialic acid receptors that are found on the host cell surface. [1]
Lamivudine is a nucleoside reverse transcriptase inhibitor and works by blocking the HIV reverse transcriptase and hepatitis B virus polymerase. [1] Lamivudine was patented in 1995 and approved for use in the United States in 1995. [8] [9] It is on the World Health Organization's List of Essential Medicines. [10] It is available as a generic ...
The virus wraps its delicate nucleic acid with a protein shell known as the capsid, from the Latin capsa, meaning "box," in order to shield it from this hostile environment. Similar to how numerous bricks come together to form a wall, the capsid is made up of one or more distinct protein types that repeatedly repeat to form the whole capsid.
Enfuvirtide binds to gp41 preventing the creation of an entry pore for the capsid of the virus, keeping it out of the cell. [ 3 ] Enfuvirtide is also an activator of the chemotactic factor receptor, formyl peptide receptor 1, and thereby activates phagocytes and presumably other cells bearing this receptor (see formyl peptide receptors ). [ 4 ]